SRI has developed a promising new treatment for this cancer of the immune system that affects plasma cells in bone marrow.
SRI is identifying candidates for advanced therapies in multiple disease areas by developing compounds from synthetically optimized, natural dietary products.
Novel molecular targets of several cytokines are being evaluated by SRI scientists, with the goal of designing a small-molecule drug to block responses involved in many of these inflammatory diseases.
SRI is seeking new treatments for tuberculosis, a global health crisis.
SRI is developing a new therapeutic agent for influenza virus infections.
SRI is elucidating the mechanism of action of the drug of choice for the treatment of all known forms of human schistosomiasis.
SRI is enabling and improving metabolomics research with high-quality reference standards.
SRI has patented a novel approach to vaccine delivery that is safe for pediatric use, eliminating the need for painful injections.
SRI sleep researchers are working to discover and develop new treatments for narcoleptic patients.